Cargando…
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
During their development and progression tumors acquire numerous mutations that, when translated into proteins give rise to neoantigens that can be recognized by T cells. Initially, neoantigens were not recognized as preferred targets for cancer immunotherapy due to their enormous diversity and the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742119/ https://www.ncbi.nlm.nih.gov/pubmed/29312332 http://dx.doi.org/10.3389/fimmu.2017.01848 |